机译:First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin
Department of Urology Northwestern University Feinberg School of Medicine;
Department of Pathology Northwestern University Feinberg School of Medicine;
Division of Biostatistics Department of Preventive Medicine Northwestern University Feinberg SchoolDivision of Rheumatology Northwestern University Feinberg School of MedicineDepartment of Urology UT Health San AntonioDivision of Hematology and Oncology Department of Medicine Rush Medical College;
Bacillus Calmette-Guérin; Bladder cancer; Clinical trial; Digital spatial profiling; Intravesical pembrolizumab;